Amit Jain

3.1k total citations · 1 hit paper
60 papers, 1.7k citations indexed

About

Amit Jain is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Amit Jain has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 16 papers in Surgery. Recurrent topics in Amit Jain's work include Lung Cancer Treatments and Mutations (13 papers), Scoliosis diagnosis and treatment (7 papers) and Spine and Intervertebral Disc Pathology (6 papers). Amit Jain is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Scoliosis diagnosis and treatment (7 papers) and Spine and Intervertebral Disc Pathology (6 papers). Amit Jain collaborates with scholars based in United States, Singapore and India. Amit Jain's co-authors include Dario Campana, Noriko Shimasaki, Wan‐Teck Lim, Eng-Huat Tan, Bhavna Chawla, Rajvardhan Azad, Mei‐Kim Ang, Han Chong Toh, Whay Kuang Chia and Daniel S.W. Tan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Nature Reviews Drug Discovery.

In The Last Decade

Amit Jain

55 papers receiving 1.7k citations

Hit Papers

NK cells for cancer immunotherapy 2020 2026 2022 2024 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NK cells for cancer immunotherapy
    2020 879 citations Noriko Shimasaki, Amit Jain et al. Nature Reviews Drug Discovery profile →

Peers

Amit Jain
Rahul Ladwa Australia
Alessandra Curioni‐Fontecedro Switzerland
Nicholas Willumsen Denmark
Neeha Zaidi United States
Italia Grenga United States
Stefan Kasper Germany
Leila Khoja United Kingdom
Marcus Tan United States
Aurélie Bertaut France
Ludmila Umansky Germany
Rahul Ladwa Australia
Amit Jain
Citations per year, relative to Amit Jain Amit Jain (= 1×) peers Rahul Ladwa

Countries citing papers authored by Amit Jain

Since Specialization
Citations

This map shows the geographic impact of Amit Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Jain more than expected).

Fields of papers citing papers by Amit Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Jain. The network helps show where Amit Jain may publish in the future.

Co-authorship network of co-authors of Amit Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Jain. A scholar is included among the top collaborators of Amit Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Jain. Amit Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Wan‐Teck, Hsiang‐Fong Kao, Lisda Suteja, et al.. (2023). Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma. Nature Communications. 14(1). 2781–2781. 25 indexed citations
2.
Tan, Wan Ling, Sze Huey Tan, Daniel S.W. Tan, et al.. (2023). EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer. Journal of Thoracic Oncology. 18(11). S652–S653.
3.
Saltman, David L., Matthew G. Varga, Nicole S. Croteau, et al.. (2022). 27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study. Clinical Lung Cancer. 24(2). 137–144. 2 indexed citations
4.
5.
Shimasaki, Noriko, Amit Jain, & Dario Campana. (2020). NK cells for cancer immunotherapy. Nature Reviews Drug Discovery. 19(3). 200–218. 879 indexed citations breakdown →
6.
Jain, Amit, et al.. (2020). Association Between Pesticide Use and Incidence of Diffuse Large B-Cell Lymphoma. Anticancer Research. 40(10). 5423–5426. 4 indexed citations
7.
Ng, Quan Sing, Daniel S.W. Tan, Wan Ling Tan, et al.. (2020). 266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939. Annals of Oncology. 31. S1347–S1347. 7 indexed citations
8.
Jain, Amit, Amina Chaudhry, Michael P. Berry, et al.. (2020). Unusual recurrent metastasizing benign breast papilloma: a case report. Journal of Medical Case Reports. 14(1). 33–33. 1 indexed citations
9.
Jain, Amit, et al.. (2019). Surgical margins and nodal metastasis are prognostic factors in oral squamous cell carcinoma: A meta-analysis. Clinical Cancer Investigation Journal. 8(2). 47.
10.
11.
Alkaff, Syed Muhammad Fahmy, Jeffrey Chun Tatt Lim, Maryam Hazly Hilmy, et al.. (2018). An integrated automated multispectral imaging technique that simultaneously detects and quantitates viral RNA and immune cell protein markers in fixed sections from Epstein-Barr virus-related tumours. Annals of Diagnostic Pathology. 37. 12–19. 17 indexed citations
12.
Ng, Terence, Yin Ting Cheung, Hui Ling Yeo, et al.. (2018). Distinct and heterogeneous trajectories of self‐perceived cognitive impairment among Asian breast cancer survivors. Psycho-Oncology. 27(4). 1185–1192. 46 indexed citations
13.
Ng, Quan Sing, Cindy Lim, Eng Huat Tan, et al.. (2018). Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases. BMC Cancer. 18(1). 1198–1198. 19 indexed citations
14.
Maruf, Mahir, et al.. (2017). Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database. International Urology and Nephrology. 50(2). 257–262. 2 indexed citations
15.
DiBianco, John Michael, Julie Y. An, Mahir Maruf, et al.. (2017). Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau. Urology Case Reports. 13. 101–103. 1 indexed citations
16.
Chawla, Bhavna, Amit Jain, Rachna Seth, et al.. (2016). Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study. Indian Journal of Ophthalmology. 64(7). 524–524. 16 indexed citations
17.
Tan, Wan Ling, et al.. (2016). 139PD: Lifetime incidence of brain metastases (BM) in EGFR-mutant (M+) lung cancer treated with first-line EGFR TKIs. Journal of Thoracic Oncology. 11(4). S117–S117. 3 indexed citations
18.
Jain, Amit, Whay Kuang Chia, & Han Chong Toh. (2016). Immunotherapy for nasopharyngeal cancer—a review. Chinese Clinical Oncology. 5(2). 22–22. 50 indexed citations
19.
Chawla, Bhavna, Amit Jain, & Rajvardhan Azad. (2013). Conservative treatment modalities in retinoblastoma. Indian Journal of Ophthalmology. 61(9). 479–479. 54 indexed citations
20.
Jain, Amit & Michael W. Ross. (2008). Predictors of Drop-Out in an Internet Study of Men Who Have Sex with Men. CyberPsychology & Behavior. 11(5). 583–586. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahul Ladwa Breakdown of academic impact, for papers by Alessandra Curioni‐Fontecedro Breakdown of academic impact, for papers by Nicholas Willumsen Breakdown of academic impact, for papers by Neeha Zaidi Breakdown of academic impact, for papers by Italia Grenga Breakdown of academic impact, for papers by Stefan Kasper Breakdown of academic impact, for papers by Leila Khoja Breakdown of academic impact, for papers by Marcus Tan Breakdown of academic impact, for papers by Aurélie Bertaut Breakdown of academic impact, for papers by Ludmila Umansky
Rankless by CCL
2026